Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N N Teng

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Bioconjugate Chemistry|November 1, 1990
Synthesis and characterization of gentiobiose heptaacetate conjugate vaccines that produce endotoxin-neutralizing antibodiesA K Bhattacharjee, J C Sadoff, H Collins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group studyW P McGuire, J Arseneau, J A Blessing, et al.
British Journal of Cancer|May 24, 2007
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patientsJ K Chan, R Urban, J M Hu, et al.
The Journal of Rheumatology|August 18, 1999
VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristicsR F van Vollenhoven, M M Bieber, M J Powell, et al.
British Journal of Cancer|November 8, 2006
Ovarian cancer in younger vs older women: a population-based analysisJ K Chan, R Urban, M K Cheung, et al.
British Journal of Cancer|February 24, 2006
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancersC A Hamilton, M K Cheung, K Osann, et al.
The New England Journal of Medicine|February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study GroupE J Ziegler, C J Fisher, C L Sprung, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Bioconjugate Chemistry|November 1, 1990
Synthesis and characterization of gentiobiose heptaacetate conjugate vaccines that produce endotoxin-neutralizing antibodiesA K Bhattacharjee, J C Sadoff, H Collins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: a Gynecologic Oncology Group studyW P McGuire, J Arseneau, J A Blessing, et al.
British Journal of Cancer|May 24, 2007
The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patientsJ K Chan, R Urban, J M Hu, et al.
The Journal of Rheumatology|August 18, 1999
VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristicsR F van Vollenhoven, M M Bieber, M J Powell, et al.
British Journal of Cancer|November 8, 2006
Ovarian cancer in younger vs older women: a population-based analysisJ K Chan, R Urban, M K Cheung, et al.
British Journal of Cancer|February 24, 2006
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancersC A Hamilton, M K Cheung, K Osann, et al.
The New England Journal of Medicine|February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study GroupE J Ziegler, C J Fisher, C L Sprung, et al.
Pageof 6